BIOS.BR
Price:
$0.0023
Market Cap:
$1.50M
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
Industry
Biotechnology
IPO Date
2015-02-03
Stock Exchange
BRU
Ticker
BIOS.BR
According to BioSenic S.A.’s latest financial reports and current stock price. The company's current ROE is 296.89%. This represents a change of 953.39% compared to the average of 28.18% of the last 4 quarters.
The mean historical ROE of BioSenic S.A. over the last ten years is -169.19%. The current 296.89% ROE has changed -275.48% with respect to the historical average. Over the past ten years (40 quarters), BIOS.BR's ROE was at its highest in in the June 2020 quarter at 214.72%. The ROE was at its lowest in in the December 2013 quarter at -2141.27%.
Average
-169.19%
Median
-71.47%
Minimum
-535.12%
Maximum
125.60%
Discovering the peaks and valleys of BioSenic S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 529.10%
Maximum Annual ROE = 125.60%
Minimum Annual Increase = -316.99%
Minimum Annual ROE = -535.12%
| Year | ROE | Change |
|---|---|---|
| 2023 | 125.60% | -316.99% |
| 2022 | -57.88% | -257.06% |
| 2021 | 36.85% | -110.26% |
| 2020 | -359.10% | -29.70% |
| 2019 | -510.79% | 61.34% |
| 2018 | -316.59% | -40.84% |
| 2017 | -535.12% | 529.10% |
| 2016 | -85.06% | 69.28% |
| 2015 | -50.25% | -183.12% |
| 2014 | 60.45% | -100.93% |
The current ROE of BioSenic S.A. (BIOS.BR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
34.86%
5-year avg
-153.06%
10-year avg
-169.19%
BioSenic S.A.’s ROE is less than Celyad Oncology S.A. (67.42%), less than GeNeuro S.A. (239.67%), greater than Oxurion N.V. (-17.00%), greater than Vivoryon Therapeutics N.V. (-225.69%),
| Company | ROE | Market cap |
|---|---|---|
| 67.42% | $8.28M | |
| 239.67% | $1.34M | |
| -17.00% | $575.90K | |
| -225.69% | $41.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioSenic S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioSenic S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioSenic S.A.'s ROE?
How is the ROE calculated for BioSenic S.A. (BIOS.BR)?
What is the highest ROE for BioSenic S.A. (BIOS.BR)?
What is the 3-year average ROE for BioSenic S.A. (BIOS.BR)?
What is the 5-year average ROE for BioSenic S.A. (BIOS.BR)?
How does the current ROE for BioSenic S.A. (BIOS.BR) compare to its historical average?